pravastatin has been researched along with Antiphospholipid Syndrome in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 5 (62.50) | 24.3611 |
| 2020's | 3 (37.50) | 2.80 |
| Authors | Studies |
|---|---|
| Abe, S; Kaneko, K; Kawasaki, H; Murashima, A; Sago, H; Saito, J; Suzuki, T; Yakuwa, N; Yamatani, A | 1 |
| Cervar-Zivkovic, M; Mayer-Pickel, K; Moertl, M; Schöll, W; Stern, C | 1 |
| Contento, G; Girardi, G; Jurisic, A; Jurisic, Z; Lefkou, E; Pombo, J; Varoudi, K | 1 |
| Dagklis, T; Fragakis, N; Girardi, G; Lefkou, E; Mamopoulos, A; Nounopoulos, E; Rousso, D; Vosnakis, C | 1 |
| Costantine, MM | 1 |
| Dagklis, T; Girardi, G; Lefkou, E; Mamopoulos, A; Rousso, D; Vosnakis, C | 1 |
| Lockshin, MD; Pierangeli, SS | 1 |
| Abrahams, VM; Brosens, JJ; Chamley, LW; Gariepy, A; Mulla, MJ; Odiari, EA; Paidas, MJ; Sfakianaki, AK; Stanwood, NL | 1 |
8 other study(ies) available for pravastatin and Antiphospholipid Syndrome
| Article | Year |
|---|---|
Pravastatin concentrations in maternal serum, umbilical cord serum, breast milk and neonatal serum during pregnancy and lactation: A case study.
Topics: Antiphospholipid Syndrome; Female; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Infant; Infant, Newborn; Lactation; Milk, Human; Placenta; Pravastatin; Pre-Eclampsia; Pregnancy; Umbilical Cord | 2022 |
Preeclampsia before fetal viability in women with primary antiphospholipid syndrome- materno-fetal outcomes in a series of 7 cases.
Topics: Adult; Antiphospholipid Syndrome; Female; Fetal Viability; Gestational Age; Heparin, Low-Molecular-Weight; Humans; Hydroxychloroquine; Infant, Premature; Plasma Exchange; Pravastatin; Pre-Eclampsia; Pregnancy; Pregnancy Trimester, First; Pregnancy Trimester, Second; Premature Birth; Respiratory Distress Syndrome, Newborn; Retrospective Studies; Severity of Illness Index; Time Factors | 2020 |
Triple therapy with pravastatin, low molecular weight heparin and low dose aspirin improves placental haemodynamics and pregnancy outcomes in obstetric antiphospholipid syndrome in mice and women through a nitric oxide-dependent mechanism.
Topics: Adult; Animals; Anti-Inflammatory Agents, Non-Steroidal; Anticholesteremic Agents; Anticoagulants; Antiphospholipid Syndrome; Aspirin; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Fetal Growth Retardation; Hemodynamics; Heparin, Low-Molecular-Weight; Humans; Mice; Mice, Inbred C57BL; Nitric Oxide; Placenta; Pravastatin; Pre-Eclampsia; Pregnancy; Pregnancy Complications; Pregnancy Outcome | 2020 |
Clinical improvement and successful pregnancy in a preeclamptic patient with antiphospholipid syndrome treated with pravastatin.
Topics: Adult; Antiphospholipid Syndrome; Blood Pressure; Comorbidity; Female; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Pravastatin; Pre-Eclampsia; Pregnancy; Pregnancy Complications; Pregnancy Outcome; Treatment Outcome | 2014 |
Pravastatin to prevent obstetrical complications in women with antiphospholipid syndrome.
Topics: Antiphospholipid Syndrome; Aspirin; Female; Humans; Pravastatin; Pre-Eclampsia; Pregnancy; Pregnancy Complications | 2016 |
Pravastatin improves pregnancy outcomes in obstetric antiphospholipid syndrome refractory to antithrombotic therapy.
Topics: Adult; Antiphospholipid Syndrome; Endothelium; Enoxaparin; Female; Fibrinolytic Agents; Gestational Age; Hemodynamics; Heparin, Low-Molecular-Weight; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Pravastatin; Pregnancy; Pregnancy Complications; Pregnancy Outcome; Risk Factors; Tinzaparin; Uterine Artery | 2016 |
Statins for the treatment of obstetric complications in antiphospholipid syndrome?
Topics: Abortion, Habitual; Animals; Antibodies, Antiphospholipid; Antiphospholipid Syndrome; Clinical Trials as Topic; Female; Fertility; Humans; Mice; Pravastatin; Teratoma | 2010 |
Pravastatin does not prevent antiphospholipid antibody-mediated changes in human first trimester trophoblast function.
Topics: Angiogenesis Inducing Agents; Antibodies, Antiphospholipid; Antibodies, Monoclonal; Antiphospholipid Syndrome; beta 2-Glycoprotein I; Cell Line; Cell Movement; Cytokines; Enzyme-Linked Immunosorbent Assay; Humans; Multiplex Polymerase Chain Reaction; Pravastatin; Trophoblasts | 2012 |